8-K: Trust Stamp Secures $4.3M Capital, Issues New Warrants

T Stamp Inc. has completed a warrant inducement transaction, generating $4.3 million in gross proceeds and issuing new warrants to an institutional investor.

Summary

• T Stamp Inc. entered into a warrant exercise and exchange inducement agreement with an institutional investor on October 31, 2025.
• The investor agreed to exercise all of their September 2024 Warrants (413,696 shares at an original exercise price of $4.83) and January 2025 Warrants (621,303 shares at an original exercise price of $8.45).
• As consideration, the exercise price for these existing warrants was reduced to $4.20 per share, matching the most recent Nasdaq closing price.
• The company received approximately $4.347 million in gross proceeds from this exercise, before deducting fees and expenses.
• In addition, the company issued new unregistered Series A Warrants (1,301,945 shares) and Series B Warrants (1,209,099 shares) to the investor, totaling 2,511,044 new warrants, each with an exercise price of $4.20 per share.
• The investor also exchanged all of their December 2024 Warrants (648,148 shares at an original exercise price of $8.10) for new warrants with an exercise price of $4.20 per share, which are part of the newly issued warrants.
• The new warrants are immediately exercisable and have a five-year term.
• The company is prohibited from engaging in 'Variable Rate Transactions' for 90 days following October 31, 2025.
• As of October 31, 2025, the company has 5,243,832 shares of common stock outstanding.
• Maxim Group LLC acted as the exclusive warrant solicitation agent and financial advisor, receiving a cash fee of $304,290.

Sentiment

Score: 5

Explanation: The transaction provides much-needed capital for T Stamp Inc. but comes at a significant cost of potential future dilution. While securing funds is positive, the terms (reduced exercise price

Positives

• Successfully raised approximately $4.347 million in gross proceeds, enhancing liquidity for business growth, working capital, and general corporate purposes.
• Reduced the exercise price of existing warrants to $4.20, incentivizing immediate exercise and capital infusion.
• Secured additional capital without incurring new debt, which can be beneficial for the company's balance sheet.
• The Series A Warrants include additional protections for the holder in the event of a Fundamental Transaction, such as the option for the company to repurchase warrants at their Black-Scholes Value, which could be attractive to investors.

Negatives

• Significant potential dilution from the issuance of 2,511,044 new warrants, which is approximately 47.9% of the current outstanding shares (2,511,044 / 5,243,832).
• The reduction of the exercise price for existing warrants from $4.83 and $8.45 to $4.20 indicates that the previous warrant holders were underwater, and the company had to offer a significant concession to induce exercise.
• The issuance of new warrants at 180% of the shares exercised (2,511,044 new warrants for 1,034,999 exercised shares) represents a substantial incentive, further increasing potential future dilution.
• The 90-day prohibition on 'Variable Rate Transactions' restricts the company's flexibility in future capital raising or financing activities during that period.
• The company incurred $304,290 in fees to Maxim Group LLC for the transaction, reducing the net proceeds.

Risks

• Future dilution risk from the exercise of the newly issued 2,511,044 warrants at $4.20 per share.
• Risk of further share price volatility due to the large number of warrants outstanding and the potential for their exercise and subsequent sale.
• The beneficial ownership limitation (4.99% for new warrants, 9.99% for existing warrants) could restrict the institutional investor's ability to fully exercise warrants if it would exceed the threshold, potentially delaying further capital infusion from this investor.
• Failure to deliver shares upon valid exercise of new warrants within the specified timeframe will result in liquidated damages and potential buy-in rights for the holder, posing a financial and operational risk.
• Failure to file an effective resale registration statement for the new warrants by the specified dates will result in liquidated damages payable to the holders, creating a financial penalty risk.

Future Outlook

The company intends to use the net proceeds from the warrant exercise for business growth, working capital, and general corporate purposes. It has committed to filing a resale registration statement for the newly issued warrants and underlying shares within 30 days and to ensure its effectiveness within 60-90 days. The company also agrees to maintain its Nasdaq listing and apply to list the new shares.

Management Comments

• Gareth Genner, CEO of T Stamp Inc., signed the agreements on behalf of the company.

Industry Context

This transaction provides T Stamp Inc., a global provider of AI-powered identity services, with additional capital. In the rapidly evolving identity verification and AI sectors, access to capital is crucial for research and development, market expansion, and maintaining a competitive edge. The terms of the warrant inducement, particularly the reduced exercise price and issuance of new warrants, suggest a need to incentivize existing investors to provide liquidity, which could be a common challenge for growth-stage technology companies in a fluctuating market.

Comparison to Industry Standards

• NA

Key Dates

Keywords

Warrant Inducement, Capital Raise, Equity Financing, SEC Filing, Form 8-K, T Stamp Inc., IDAI, Common Stock Warrants, Dilution, Private Placement, Financial Advisory, Nasdaq